Terms: = Thyroid cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Treatment
166 results:
1. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
2. PGR-kitLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.
Yang Z; Chen H; Yin S; Mo H; Chai F; Luo P; Li Y; Ma L; Yi Z; Sun Y; Chen Y; Wu J; Wang W; Yin T; Zhu J; Shi C; Zhang F
Cancer Lett; 2024 May; 589():216795. PubMed ID: 38556106
[TBL] [Abstract] [Full Text] [Related]
3. GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells.
Zhang X; Zhang L; Wang B; Zhang X; Gu L; Guo K; Zhang X; Zhou Z
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):221-225. PubMed ID: 38279433
[TBL] [Abstract] [Full Text] [Related]
4. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
5. SLC35A2 expression drives breast cancer progression via ERK pathway activation.
Yang X; Tao Y; Xu Y; Cai W; Shao Q
FEBS J; 2024 Apr; 291(7):1483-1505. PubMed ID: 38143314
[TBL] [Abstract] [Full Text] [Related]
6. TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage.
Chang S; Xiao W; Xie Y; Xu Z; Li B; Wang G; Hu K; Zhang Y; Zhou J; Song D; Zhu H; Wu X; Lu Y; Shi J; Zhu W
Cancer Med; 2023 Dec; 12(23):21321-21334. PubMed ID: 37942576
[TBL] [Abstract] [Full Text] [Related]
7. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
8. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
Wang D; Liu X; Li M; Ning J
Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
[TBL] [Abstract] [Full Text] [Related]
9. Ubiquitin-specific peptidase 10 attenuates the ferroptosis to promote thyroid cancer malignancy by facilitating GPX4 via elevating SIRT6.
Lian F; Dong D; Pu J; Yang G; Yang J; Yang S; Wang Y; Zhao B; Lu M
Environ Toxicol; 2024 Mar; 39(3):1129-1139. PubMed ID: 37860888
[TBL] [Abstract] [Full Text] [Related]
10. Ononin Relieves the thyroid cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels.
Du L; Zeng D; Hu X; Ren X; He D
Biol Pharm Bull; 2023; 46(8):1041-1048. PubMed ID: 37532555
[TBL] [Abstract] [Full Text] [Related]
11. Highly Sensitive Enrichment of Low-Frequency Variants by Hairpin Competition Amplification.
Liu Z; Zhang R; Jiang X; Ji L; Sun P; Ji Y; Zhang Y; Ding Y; Li K; Pu Z; Zhou F; Zou J
Anal Chem; 2023 Aug; 95(32):12015-12023. PubMed ID: 37527514
[TBL] [Abstract] [Full Text] [Related]
12. Aberrantly Expressed lncRNA LINC00847 May Serve as a Promising Prognostic Factor for thyroid cancer.
Hei G; Yu Y; Wu Y; Huang J
Horm Metab Res; 2023 Nov; 55(11):794-800. PubMed ID: 37493640
[TBL] [Abstract] [Full Text] [Related]
13. RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway.
Ayoufu A; Paierhati P; Qiao L; Zhang N; Abudukeremu M
Thorac Cancer; 2023 Aug; 14(24):2504-2514. PubMed ID: 37429610
[TBL] [Abstract] [Full Text] [Related]
14. ELK1/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism.
Yang B; Wang H; Xiao J; Chen W; Chen W
J Obstet Gynaecol Res; 2023 Aug; 49(8):2175-2184. PubMed ID: 37339943
[TBL] [Abstract] [Full Text] [Related]
15. CircRNA CircABCB1 Diminishes the Sensitivity of Breast cancer Cells to Docetaxel by Sponging MiR-153-3p.
Liu J; Kong L; Bian W; Lin X; Wei F; Chu J
Tohoku J Exp Med; 2023 Sep; 261(1):25-33. PubMed ID: 37164696
[TBL] [Abstract] [Full Text] [Related]
16. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.
Huang X; Tan W; Liu Z; Fu X; Li Z; Lai S; Li Q; Zhong X; Qu F; Zhang H; Li H
Life Sci; 2023 Jul; 324():121745. PubMed ID: 37127184
[TBL] [Abstract] [Full Text] [Related]
17. [Duodenal bleeding due to metastasis from lung adenocarcinoma controlled by radiotherapy: A case report and literature review].
Severin S; Terrones Munoz V; Meert N; Peche R
Rev Mal Respir; 2023 Apr; 40(4):359-365. PubMed ID: 36868976
[TBL] [Abstract] [Full Text] [Related]
18. Vitamin D Status in Patients before thyroidectomy.
Maciejewska-Markiewicz D; Kochman J; Jakubczyk K; Bargiel P; Szlosser Z; Stachowska E; Markowska M; Bucka A; Czapla N; Petriczko J; Surówka A; Hertman S; Puchalski P; Prowans P
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834638
[TBL] [Abstract] [Full Text] [Related]
19. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
[TBL] [Abstract] [Full Text] [Related]
20. Antineoplastic Activity of Pazopanib in Anaplastic thyroid cancer in Primary Culture.
Ferrari SM; Elia G; Ragusa F; Paparo SR; Mazzi V; Patrizio A; Piaggi S; Baldini E; Centanni M; La Motta C; Antonelli A; Fallahi P
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768721
[TBL] [Abstract] [Full Text] [Related]
[Next]
